The WOCN Society 40th Annual Conference (June 21-25th, 2008)


2345

Clinical evaluation of a new foam dressing with and without adhesive for the local management of acute and chronic wounds

Elizabeth Konz, PhD, RD, Hollister Incorporated, Sr. Clinical Research Scientist, 2000 Libertyville Drive, Libertyville, IL 60048 and Serge Bohbot, Laboratoires Urgo, Medical Director, 42 rue de Longvic, Chenove, 21300, France.

Statement of the Problem: Foam dressings are commonly used for moderate to heavily exudating chronic and acute wounds. When choosing an appropriate dressing, the potential for wound healing and a reduction of pain to the patient must be considered. Non-adherence, ease of application and removal of the dressing, are all features that contribute to the potential for a wound to heal and the reduction of pain during dressing removal.

Methodology: This was an open-label, non-randomized evaluation of a new foam dressing introduced in the US conducted at 9 US sites. Study subjects were selected from the general population of patients with acute and chronic wounds for which the clinician found a foam dressing would be appropriate. Specific questions were asked to obtain the clinicians' perception of performance characteristics of the products.

Results Thirty-five wounds had the foam applied (21 chronic, 14 acute). Descriptive statistics of clinician perception of the ease of application, adherence to wound, and pain during removal of the foam dressing were assessed. In addition, the overall clinical assessment of wound healing will be discussed.

Conclusion The new foam was easily applied and removed with minimal to no adhesion to the wound bed. This may decrease patient pain during dressing removal and promote the wound healing process in the chronic and acute wounds observed in this product evaluation.

*Product used was UrgoCell Adhesive and UrgoCell Non-adhesive (Laboratoires URGO, Dijon, France) marketed in the US as Restore Foam Adhesive and Restore Foam Non-adhesive by Hollister Wound Care, LLC.